Imatinib
Entry of a Generic into the Market May Not Mean Big Savings
It usually takes more than one generic to drive down prices, experts said.
MAY 28, 2018
Trial Compares Bosutinib and Imatinib for First-Line CML Rx
Chicago—A Phase III head-to-head trial of bosutinib and imatinib for first-line treatment of chronic myeloid ...
SEPTEMBER 21, 2017
ABCB1 Overexpression Predicts Poor Imatinib Response in CML Patients
High expression of ABCB1 predicts a poor response to imatinib among patients with chronic myeloid leukemia
AUGUST 9, 2016
Generic Imatinib Posed As Most Cost-Effective Initial CML Strategy
Using generic imatinib and then switching to other tyrosine kinase inhibitors (TKIs) if intolerance or lack of ...
JUNE 14, 2016
Stopping Imatinib Safe for CML Pts With Deep Response
Orlando, Fla.—Five-year data from the STIM (STOP Imatinib) study have reconfirmed that it is feasible to ...
MARCH 5, 2016
